Maturitas
Volume 59, Issue 3 , Pages 282-283 , 20 March 2008

  • D.E. Jacobsen

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Geriatric Medicine, University Medical Centre Utrecht, PO Box 85500, Room B05.256, 3508 GA Utrecht, The Netherlands. Tel.: +31 302508280.
    • ,
  • M.M. Samson

Received 24 October 2007

References 

  1. Chao KC, Wang PH, Yen MS, Huang CY, Twu NF, Wu HS. New selective tissue estrogenic activity regulator in menopausal therapy in Taiwan. Taiwan J Obstet Gynecol. 2005;44:327–331
  2. Bianco V, Murina F, Roberti P, Valente I. Tibolone in treatment of menopause: compliance, efficacy and safety in a ten-year experience. Minerva Ginecol. 2006;58:335–344
  3. Kongnyuy EJ, Norman RJ, Flight IHK, Rees MCP, Oestrogen and progestagen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews, issue 3; 1999. Art. no.: CD001018. doi:10.1002/14651858.CD001018.
  4. Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ. The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women. Endocrinology. 2001;142(11):4813–4817
  5. Hänggi W, Lippuner K, Jaeger P, et al. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol. 1998;48:691–699
  6. Boyanov MA, Shinkov AD. Effects of tibolone on body composition in postmenopausal women: a 1 year follow up study. Maturitas. 2005;51(4):363–369
  7. Brooke-Wavell K, Prelevic GM, Bakridan C, Ginsburg J. Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women—a cross-sectional study. Maturitas. 2001;37:167–172
  8. Arabi A, Garnero P, Porcher R, et al. Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. Human Reprod. 2003;18(8):1747–1752
  9. Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, et al. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause. 2005;13(4):660–668

PII: S0378-5122(07)00320-9

doi: 10.1016/j.maturitas.2007.10.012

Maturitas
Volume 59, Issue 3 , Pages 282-283 , 20 March 2008

Article Tools